Laura Towart, Founder and CEO at Vivan Therapeutics, member of 100 Influential Women in Oncology, shared a post on LinkedIn:
“Proud to be recognized among Britain’s leading AI innovators
We’re thrilled to announce that Vivan Therapeutics has been named one of the 1,000 largest AI firms in Britain by AI Index, a forensic analysis of the top-funded AI startups headquartered in the UK.
This recognition reflects our commitment to leveraging artificial intelligence to advance therapeutic innovation and improve patient outcomes. Being part of this ecosystem is both an honor and a responsibility.
The impact of UK AI: Together, the 1,000 firms in the 2025 AI Index contribute £45 billion to the UK economy and provide 35,000 jobs across the country. Collectively, we’ve raised at least £20 billion in funding—a testament to the global confidence in British AI innovation.
Thank you to our team, partners, and supporters who make this work possible. We’re excited to continue pushing the boundaries of what’s possible at the intersection of AI and therapeutics.”
More posts featuring Laura Towart.